Zhejiang Sixian Pharmaceutical Co.,Ltd.(ZJSXPC) is an enterprise engaged in R &D and manufacturing bulk drugs and intermediates. The company has national GMP and international ISO14001 certification. The total assets of the company amount to as much as over RMB ￥150 million,including the capital assets of RMB ￥65 million. It covers an area of over thirty thousand m2. The company has four workshops and one well-equipped R&D and Quality Inspection Center. Its main products are:Rifaximin,Trimethyacetaldehyde/Pivalaldehyde,Levofloxacin lactate,Rifamycin-O,Pyruvic aldehyde dimethyl acetal,Cyclic acid....etc.. The products are sold in most of the regions in China and more than twenty countries in the world.
ZJSXPC's tenet is "serving the people and the society" and its policies are "management scientific, quality first , service excellent , creditability reliable" in order to improve product quality, offer strong technical support, achieve high-profit management and provide high quality products and satisfactory customer services. The company have employed all kinds of skilled professionals who accounted for 34% of all the employees. In order to implement the company culture characterized by “diligence, honesty,practicality, and unity”, the company follows management’s concept of “ People-Oriented” to strengthen the bonding of the company and its employees.
Sixian pharmaceutical company Ltd. holds “Technology-Primacy” as its developing philosophy, insists its developing path grounded on “Advanced Technology”. The company pays more attention to the research, development and High-Tech. products and marketing them. It has a well-established cooperative relationship with many research institutes within the country, such as Shanghai Organic Research Branch of Chinese Academic Institute, Zhejiang University, Chinese pharmaceutical University, and many domestic pharmaceutical companies.